RareGen, LLC

RareGen, LLC is a Durham, North Carolina-based company specializing in strategy, investment, and commercialization support for rare disease pharmaceutical products. We partner with companies developing innovative therapies for rare conditions, providing critical guidance throughout the product lifecycle – from initial strategy and market analysis to securing investment and building a robust commercialization plan. RareGen’s national sales force focuses on cardiology and pulmonology specialties, leveraging deep industry expertise to accelerate the path of these vital medications to patients.

As a portfolio company of PBM Capital Group, a leading healthcare investment firm, RareGen combines strategic insight with significant resources to drive success in the complex rare disease landscape. Our approach is centered on delivering tailored solutions that maximize the potential of rare disease therapies, ultimately improving patient outcomes.